Integration of Comparative Effectiveness Research into Drug Pricing Frameworks
Integration of Comparative Effectiveness Research into Drug Pricing Frameworks

By João L. Carapinha

May 29, 2026

Contemporary comparative effectiveness research plays a vital role in supporting federal and state drug pricing programs by highlighting real-world benefits, yet persistent challenges and unclear guidance continue to limit its integration. Core principles of evidence evaluation, research question...
European Pharmacists Preparation for Health Crisis Response
European Pharmacists Preparation for Health Crisis Response
European pharmacists preparation ensures that community networks remain operational during health crises, enabling continuous patient care amid pandemics and infrastructure failures. The recently published PGEU position paper outlines seven priorities that integrate pharmacies into governance str...
Imfinzi Bladder Cancer Approval Marks Breakthrough in Immunotherapy
Imfinzi Bladder Cancer Approval Marks Breakthrough in Immunotherapy
The Imfinzi bladder cancer approval by the FDA now offers a new immunotherapy option for adults with BCG-naïve, high-risk non-muscle-invasive bladder cancer when combined with standard BCG induction and maintenance therapy. This Imfinzi bladder cancer approval stems from the POTOMAC Phase III ...
Advancements in Radioligand Therapy Prostate Cancer Treatment
Advancements in Radioligand Therapy Prostate Cancer Treatment
Radioligand Therapy Prostate Cancer has emerged as a breakthrough approach in prostate cancer treatment by linking a cancer-targeting molecule to a radioactive payload that delivers radiation directly to tumor cells. This method minimizes damage to nearby healthy tissue while demonstrating clinic...
Therapeutic Impact of Conversational Agent Interventions on Mental Health
Therapeutic Impact of Conversational Agent Interventions on Mental Health
Conversational Agent Interventions demonstrate measurable benefits for mental health, according to a meta-analysis of 48 randomized controlled trials involving 28,071 participants that found both AI-based and rule-based agents produced small-to-moderate reductions in depression (SMD −0.27), anxie...
UC Biomed Building Investment: Advancing Research at the University of Coimbra
UC Biomed Building Investment: Advancing Research at the University of Coimbra

By João L. Carapinha

May 27, 2026

The Universidade de Coimbra (UC) is preparing to inaugurate its new UC Biomed building in the coming months, marking a significant milestone for the institution's biomedical research and teaching capabilities. According to recent updates, the facility—located at Polo III—has entered its final pha...
Search By Category
Integration of Comparative Effectiveness Research into Drug Pricing Frameworks

Latest

Integration of Comparative Effectiveness Research into Drug Pricing Frameworks

By João L. Carapinha

May 29, 2026

Contemporary comparative effectiveness research plays a vital role in supporting federal and state drug pricing programs by highlighting real-world benefits, yet persistent challenges and unclear guidance continue to limit its integration. Core principles of evidence evaluation, research question...
European Pharmacists Preparation for Health Crisis Response

Latest

European Pharmacists Preparation for Health Crisis Response
European pharmacists preparation ensures that community networks remain operational during health crises, enabling continuous patient care amid pandemics and infrastructure failures. The recently published PGEU position paper outlines seven priorities that integrate pharmacies into governance str...
Imfinzi Bladder Cancer Approval Marks Breakthrough in Immunotherapy

Latest

Imfinzi Bladder Cancer Approval Marks Breakthrough in Immunotherapy
The Imfinzi bladder cancer approval by the FDA now offers a new immunotherapy option for adults with BCG-naïve, high-risk non-muscle-invasive bladder cancer when combined with standard BCG induction and maintenance therapy. This Imfinzi bladder cancer approval stems from the POTOMAC Phase III ...
Advancements in Radioligand Therapy Prostate Cancer Treatment

Latest

Advancements in Radioligand Therapy Prostate Cancer Treatment
Radioligand Therapy Prostate Cancer has emerged as a breakthrough approach in prostate cancer treatment by linking a cancer-targeting molecule to a radioactive payload that delivers radiation directly to tumor cells. This method minimizes damage to nearby healthy tissue while demonstrating clinic...
Key Milestone in GBA-PD Therapy Development Achieved with ACTIVATE Study Completion

Global Updates

Key Milestone in GBA-PD Therapy Development Achieved with ACTIVATE Study Completion

By João L. Carapinha

May 26, 2026

Bial announced the completion of the treatment period in its Phase 2b ACTIVATE study evaluating BIA 28-6156 (pariceract) in patients with Parkinson’s disease (PD) who carry a pathogenic mutation in the glucocerebrosidase 1 (GBA1) gene, referred to as GBA-PD. The 78-week double-blind treatment pha...
Innovative Insights into Menstrual Health Monitoring Through Wearable Technology

Global Updates

Innovative Insights into Menstrual Health Monitoring Through Wearable Technology
An analysis of 1.2 million days of data from 2,596 women across 42,759 menstrual cycles demonstrates that cycle length strongly influences the magnitude of fluctuations in cardiorespiratory biometrics, while shorter sleep durations correlate with greater cycle length deviation. Resting heart rate...
Emergence of AI Healthcare Policy Amidst Fragmentation and Governance Challenges

Global Updates

Emergence of AI Healthcare Policy Amidst Fragmentation and Governance Challenges

By João L. Carapinha

May 25, 2026

The rapid evolution of AI Healthcare Policy is evident in the Health & AI Policy Index (HAPI) snapshot from January 1, 2026, which catalogs 240 policies illustrating swift expansion of artificial intelligence governance across U...
Hepcludex HDV Approval: A Breakthrough in Chronic Hepatitis Delta Treatment

Global Updates

Hepcludex HDV Approval: A Breakthrough in Chronic Hepatitis Delta Treatment
The U.S. Food and Drug Administration approved Hepcludex (bulevirtide-gmod) injection as the first treatment for chronic hepatitis delta virus (HDV) infection in adults without cirrhosis or with compensated cirrhosis. This Hepcludex HDV approval addresses a previously unmet need for patients faci...

Upcoming Global Events

Upcoming Events:
June 6-10, 2026 HTAi 2026 Annual Meeting | Istanbul, Turkey Website →
June 9-11, 2026 World Orphan Drug Congress USA | Thomas M. Menino Convention & Exhibition Center, Boston, MA, USA Website →
June 29-30, 2026 GetReal Institute Annual Conference 2026 | Utrecht, Crowne Plaza, The Netherlands Website →

Europe

European Pharmacists Preparation for Health Crisis Response
European Pharmacists Preparation for Health Crisis Response

By João L. Carapinha

May 29, 2026

European pharmacists preparation ensures that community networks remain operational during health crises, enabling continuous patient care amid pandemics and infrastructure failures. The recently published PGEU position paper outlines seven priorities that integrate pharmacies into governance str...
Advancements in Radioligand Therapy Prostate Cancer Treatment
Advancements in Radioligand Therapy Prostate Cancer Treatment
Radioligand Therapy Prostate Cancer has emerged as a breakthrough approach in prostate cancer treatment by linking a cancer-targeting molecule to a radioactive payload that delivers radiation directly to tumor cells. This method minimizes damage to nearby healthy tissue while demonstrating clinic...
Therapeutic Impact of Conversational Agent Interventions on Mental Health
Therapeutic Impact of Conversational Agent Interventions on Mental Health
Conversational Agent Interventions demonstrate measurable benefits for mental health, according to a meta-analysis of 48 randomized controlled trials involving 28,071 participants that found both AI-based and rule-based agents produced small-to-moderate reductions in depression (SMD −0.27), anxie...
UC Biomed Building Investment: Advancing Research at the University of Coimbra
UC Biomed Building Investment: Advancing Research at the University of Coimbra

By João L. Carapinha

May 27, 2026

The Universidade de Coimbra (UC) is preparing to inaugurate its new UC Biomed building in the coming months, marking a significant milestone for the institution's biomedical research and teaching capabilities. According to recent updates, the facility—located at Polo III—has entered its final pha...

North America

Integration of Comparative Effectiveness Research into Drug Pricing Frameworks
Integration of Comparative Effectiveness Research into Drug Pricing Frameworks

By João L. Carapinha

May 29, 2026

Contemporary comparative effectiveness research plays a vital role in supporting federal and state drug pricing programs by highlighting real-world benefits, yet persistent challenges and unclear guidance continue to limit its integration. Core principles of evidence evaluation, research question...
Imfinzi Bladder Cancer Approval Marks Breakthrough in Immunotherapy
Imfinzi Bladder Cancer Approval Marks Breakthrough in Immunotherapy
The Imfinzi bladder cancer approval by the FDA now offers a new immunotherapy option for adults with BCG-naïve, high-risk non-muscle-invasive bladder cancer when combined with standard BCG induction and maintenance therapy. This Imfinzi bladder cancer approval stems from the POTOMAC Phase III ...
Therapeutic Impact of Conversational Agent Interventions on Mental Health
Therapeutic Impact of Conversational Agent Interventions on Mental Health
Conversational Agent Interventions demonstrate measurable benefits for mental health, according to a meta-analysis of 48 randomized controlled trials involving 28,071 participants that found both AI-based and rule-based agents produced small-to-moderate reductions in depression (SMD −0.27), anxie...
Innovative Insights into Menstrual Health Monitoring Through Wearable Technology
Innovative Insights into Menstrual Health Monitoring Through Wearable Technology

By João L. Carapinha

May 26, 2026

An analysis of 1.2 million days of data from 2,596 women across 42,759 menstrual cycles demonstrates that cycle length strongly influences the magnitude of fluctuations in cardiorespiratory biometrics, while shorter sleep durations correlate with greater cycle length deviation. Resting heart rate...

Sub-Saharan Africa

SAHPRA SAPC Regulatory Enforcement: Addressing Unregistered GLP-1 and GIP Products
SAHPRA SAPC Regulatory Enforcement: Addressing Unregistered GLP-1 and GIP Products
SAHPRA SAPC regulatory enforcement has intensified following the seizure of all GLP-1 and GIP injectable products at iDexis (Pty) Ltd trading as Sentra Pharmacy. An inspection on 11 May 2026 revealed the facility was manufacturing and distributing unregistered medicines containing semaglutide, ti...
Substandard Medicines in South Africa: Regulatory Challenges and Economic Implications
Substandard Medicines in South Africa: Regulatory Challenges and Economic Implications

By HEOR Staff Writer

May 21, 2026

Substandard medicines in South Africa continue to infiltrate supply chains through informal markets, unlicensed outlets, and online platforms, leaving patients exposed to unregulated weight-loss injections amid stock shortages and high costs for approved options such as Ozempic. Comp...
Transforming Healthcare Value: Strategic Purchasing in South Africa
Transforming Healthcare Value: Strategic Purchasing in South Africa

By João L. Carapinha

May 20, 2026

Strategic Purchasing Healthcare offers a pathway for South Africa’s healthcare system to deliver improved patient outcomes amid constrained resources, where traditional passive purchasing models relying on historical budgets or uncapped fee-for-service payments have fallen short in prioritising e...
Learning from Global Best Practices in Healthcare Pricing Regulation
Learning from Global Best Practices in Healthcare Pricing Regulation
South Africa continues to face persistent challenges in establishing sustainable healthcare pricing regulation mechanisms, as highlighted in the keynote address at the CMS Industry Indaba. Countries including the United Kingdom, Japan, South Korea, and Thailand have implemented structured price-s...